These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9587856)
1. Clinical evaluation and analysis of heart valve substitutes. Grunkemeier GL; Anderson WN J Heart Valve Dis; 1998 Mar; 7(2):163-9. PubMed ID: 9587856 [TBL] [Abstract][Full Text] [Related]
2. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. Grunkemeier GL; Jin R; Starr A Ann Thorac Surg; 2006 Sep; 82(3):776-80. PubMed ID: 16928482 [TBL] [Abstract][Full Text] [Related]
3. FDA's requirements for in-vivo performance data for prosthetic heart valves. Johnson DM; Sapirstein W J Heart Valve Dis; 1994 Jul; 3(4):350-5. PubMed ID: 7952304 [TBL] [Abstract][Full Text] [Related]
4. Sample size requirements for evaluating heart valves with constant risk events. Grunkemeier GL; Johnson DM; Naftel DC J Heart Valve Dis; 1994 Jan; 3(1):53-8. PubMed ID: 8162217 [TBL] [Abstract][Full Text] [Related]
5. The International Standard Cardiovascular implants--Cardiac Valve Prostheses (ISO 5840:1989) and the FDA Draft Replacement Heart Valve Guidance (Version 4.0). Nolan SP J Heart Valve Dis; 1994 Jul; 3(4):347-9. PubMed ID: 7952303 [No Abstract] [Full Text] [Related]
6. The current state of in-vivo pre-clinical animal models for heart valve evaluation. Gallegos RP; Nockel PJ; Rivard AL; Bianco RW J Heart Valve Dis; 2005 May; 14(3):423-32. PubMed ID: 15974538 [TBL] [Abstract][Full Text] [Related]
7. FDA's requirements for in-vitro performance data for prosthetic heart valves. Johnson DM; Chwirut DJ; Regnault WF J Heart Valve Dis; 1994 May; 3(3):228-34. PubMed ID: 8087255 [TBL] [Abstract][Full Text] [Related]
8. The real impact of randomized clinical trials in heart valve surgery. Ye J; Jamieson WE Curr Opin Cardiol; 2006 Mar; 21(2):106-12. PubMed ID: 16470145 [TBL] [Abstract][Full Text] [Related]
9. Will randomized trials detect random valve failure? Reflections on a recent FDA workshop. Grunkemeier GL J Heart Valve Dis; 1993 Jul; 2(4):424-9. PubMed ID: 8269145 [No Abstract] [Full Text] [Related]
11. FDA perspective on clinical trial design for cardiovascular devices. Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481 [No Abstract] [Full Text] [Related]
12. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective. Sapirstein W Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379 [No Abstract] [Full Text] [Related]
13. Fluid dynamic studies for the year 2000. Yoganathan AP; Ellis JT; Healy TM; Chatzimavroudis GP J Heart Valve Dis; 1998 Mar; 7(2):130-9. PubMed ID: 9587852 [TBL] [Abstract][Full Text] [Related]
14. The new FDA guidelines. Bodnar E J Heart Valve Dis; 1994 May; 3(3):226-7. PubMed ID: 8087254 [No Abstract] [Full Text] [Related]
15. Ongoing FDA evaluation of approved endovascular grafts. Abel DB J Vasc Surg; 2003 Apr; 37(4):902-3; discussion 903. PubMed ID: 12663998 [No Abstract] [Full Text] [Related]